Quarter Financials
Galectin Therapeutics Inc. (GALT)
$1.54
-0.01 (-0.65%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -30 | -9 | -10 | -10 | -7 | -9 | -8 | -6 |
|---|
| Dividend Paid | -0 | - | -0 | - | 0 | - | - | - |
|---|
| Retained Earnings | -310 | -299 | -290 | -281 | -271 | -263 | -255 | -246 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | - | 1 | - | 0 | - | - | - | - |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|